What is a terminal disclaimer in patent law?

A terminal disclaimer is a formal filing by which a patent applicant or patentee gives up the entire term or any terminal part of the term of a patent. The statutory authority is 35 U.S.C. § 253(b), which permits any patentee or applicant to disclaim or dedicate to the public the entire term, or any terminal part of the term, of a patent granted or to be granted.

In U.S. patent prosecution, terminal disclaimers serve one primary function: overcoming a nonstatutory (obviousness-type) double patenting rejection.

Why terminal disclaimers arise

Nonstatutory double patenting is a judicially created doctrine designed to prevent unjustified timewise extension of patent exclusivity by preventing an applicant from obtaining a second patent whose claims are not patentably distinct from a first patent. The rejection arises when at least one examined application claim is not patentably distinct from the reference claims of a patent or application that shares the same inventive entity, at least one common inventor, a common applicant, or a common owner. This most often surfaces between a continuation and its parent, which share a disclosure and an applicant.

A terminal disclaimer is the standard remedy for such a rejection. Filing one commits the applicant to cutting the later patent's term so it does not extend beyond the expiration of the reference patent, eliminating the unjustified term extension the doctrine targets.

A terminal disclaimer can overcome a nonstatutory double patenting rejection, but it cannot overcome a statutory double patenting rejection under 35 U.S.C. § 101. Statutory double patenting can only be resolved by canceling or amending the conflicting claims so they are no longer coextensive in scope.

Terminal disclaimers may also be filed in reexamination proceedings to address nonstatutory double patenting rejections that arise during reexamination.

What the disclaimer must contain

When filed to overcome a nonstatutory double patenting rejection, the terminal disclaimer must comply with 37 CFR § 1.321(c) and include a provision that the patent will be enforceable only for and during the period that it is commonly owned with the reference patent or application. That common-ownership tie is the substantive core of the filing.

Additional formal requirements:

• Signature. The disclaimer must be signed by the applicant, the patentee, or an attorney or agent of record.
• Whole-patent scope. The disclaimer must cover a terminal portion of the term of the entire patent. Disclaiming only the term of individual claims is not accepted.
• No conditions. A terminal disclaimer may not be conditioned on any patent term adjustment outcome, litigation result, allowance of certain claims, or grant of a petition. Conditional disclaimers are not accepted.

Effect on patent term and patent term adjustment

A terminal disclaimer shortens the patent's term by capping its expiration at (or before) the reference patent's expiration date. Under 35 U.S.C. § 154(b)(2)(B), no patent whose term has been disclaimed beyond a specified date may be adjusted by patent term adjustment (PTA) beyond that disclaimed expiration date, meaning any PTA earned during prosecution cannot push the patent's expiration past the terminal disclaimer date.

A terminal disclaimer filed after the reference patent has already expired is ineffective and will not resolve the double patenting rejection.

The common-ownership tie and enforceability

The common-ownership requirement governs enforceability for the entire life of the patent. If the disclaimed patent and the reference patent end up in separate ownership, the disclaimed patent becomes unenforceable for the period of separate ownership. The disclaimer runs with the patent and binds successors and assigns, meaning this restriction follows the patent through any assignment or corporate transaction.

This creates a lasting due diligence obligation. Before assigning, licensing, or selling either patent in a family tied by a terminal disclaimer, practitioners and deal teams should confirm whether the transfer severs common ownership. If it does, the disclaimed patent loses enforceability for the period of separation.

Joint research agreement situations

When two patents form a double patenting conflict because they are related through a joint research agreement rather than direct common ownership, 37 CFR § 1.321(d) provides a separate terminal disclaimer form that must include a provision that the two patents will not be separately enforced, rather than a common-ownership tie.

Terminal disclaimer vs. claim amendment: the strategic choice

When facing an ODP rejection, an applicant has two paths: file a terminal disclaimer or amend the claims to achieve patentable distinction from the reference patent.

Claim amendment avoids the common-ownership tie and its enforceability risk, but may narrow claim scope and reduce the patent's commercial value. A terminal disclaimer preserves broader claims but permanently binds all future owners of both patents.

Neither path is universally preferable. The right choice depends on the applicant's ownership structure, the importance of claim breadth, and plans for future assignments or portfolio transactions.